Wegovy^® Weight Loss Pills

Yes, you can buy Wegovy pills online in the UK from a GPhC-registered pharmacy after completing an online consultation with a UK-registered prescriber.

Oral semaglutide, sold under the brand name Wegovy, was approved by the MHRA on 11 June 2026 for weight management in eligible adults. As a prescription-only medicine (POM), it cannot be sold without a proper assessment of your BMI, medical history and current medication.

Yes, Wegovy pills are a prescription-only medicine (POM) in the UK, so you cannot buy them without a valid prescription from a registered prescriber.

A prescriber reviews your BMI, weight-related health conditions and current medicines during an online consultation before deciding whether oral semaglutide is appropriate for you. This assessment is a legal requirement, not a formality, and it helps identify anyone who should not take the Wegovy Pill.

No, the Wegovy Pill is not currently available on the NHS and can only be obtained privately through a prescriber-led online consultation.

The MHRA approved oral semaglutide for weight management on 11 June 2026, but NHS funding requires a separate NICE technology appraisal, which had not concluded as of mid-2026. Injectable Wegovy is already available through some NHS specialist weight-management services for patients meeting strict criteria, though this pathway does not currently extend to the tablet.

At Happy Pharmacy, subscription prices per pack are £98.99 (1.5mg), £107.99 (4mg), £125.99 (9mg) and £175.49 (25mg). Single-purchase prices are £109.99, £119.99, £139.99 and £194.99 respectively.

Check the purchase options above for current prices. Treatment is subject to clinical assessment and prescriber approval.

The price depends on the strength prescribed and whether you choose a subscription or single purchase.

The current price for each option is shown in the buy box above. Your prescriber decides the appropriate dose based on clinical suitability and tolerability.

Yes, buying the Wegovy Pill online is safe if you use a GPhC-registered pharmacy that requires a genuine clinical consultation before prescribing.

Because oral semaglutide is newly launched and in high demand, unregulated websites may sell unlicensed or counterfeit versions with unverified ingredients and dosing. Before ordering, check the pharmacy's GPhC registration number and avoid any site offering Wegovy pills without a prescriber reviewing your medical history first.

Each pack contains 30 tablets, providing a 30-day supply when taken once daily.

Arrange your next supply before you run out. Follow the renewal information for your purchase option; your prescriber will confirm the appropriate strength and any dose changes.

Yes, you do not need to see your GP in person to get the Wegovy Pill through an online pharmacy.

Online pharmacies carry out a full consultation reviewed by a UK-registered prescriber, covering the same checks a GP would make, including BMI, weight-related conditions and current medicines. If oral semaglutide is not suitable for you, the prescriber will explain why and may suggest alternatives.

Yes, the Wegovy Pill and the Wegovy injection both contain the same active ingredient, semaglutide, but they are formulated differently for oral versus injectable use.

The tablet includes an absorption enhancer called SNAC, which allows semaglutide to survive stomach acid and be absorbed when swallowed. The cardiovascular risk reduction indication from the SELECT trial applies specifically to the 2.4mg injection, and dedicated long-term cardiovascular outcome data for the oral tablet are still being gathered.

No, the Wegovy Pill and Rybelsus are different licensed products, even though both are oral semaglutide tablets using SNAC technology.

Rybelsus is licensed in the UK for type 2 diabetes at doses up to 14mg, while the Wegovy Pill is a separate, higher-dose product, up to 25mg, licensed specifically for weight management in adults with obesity or overweight plus a related health condition. The two should never be substituted for one another without prescriber guidance.

Wegovy pills and the Wegovy injection produce broadly comparable weight loss, though no direct head-to-head UK trial has compared them.

In the OASIS 4 trial, the 25mg oral tablet produced average weight loss of around 16.6% at 64 weeks, close to the roughly 15% seen with the 2.4mg injection in earlier STEP trials. Trial populations differed, so this comparison is approximate, and individual results depend on adherence, dose reached and lifestyle changes.

Choosing between the Wegovy Pill and the injection depends on personal preference, since both use the same active ingredient at comparable effectiveness.

The tablet may suit you if you dislike needles, prefer a daily routine, or travel often, since it needs no refrigeration. The injection may suit you if you'd rather manage treatment weekly than follow a fasting and waiting routine each morning. Your prescriber can help you weigh these factors against your lifestyle.

Yes, the Wegovy Pill is approved by the MHRA for weight management in the UK for adults who meet specific clinical criteria.

Approval was granted on 11 June 2026 for oral semaglutide at a 25mg maintenance dose, alongside a reduced-calorie diet and increased physical activity. Eligibility generally requires a BMI of 30 or above, or 27 and above with a weight-related condition such as high blood pressure or type 2 diabetes, confirmed during your online consultation.

On average, people taking the 25mg maintenance dose of the Wegovy Pill lose around 16.6% of their body weight after 64 weeks.

This figure comes from the OASIS 4 trial, in patients with full adherence combined with diet and exercise. About 1 in 3 people achieved 20% or more weight loss, compared with roughly 3% on placebo. Individual results vary depending on starting weight, dose reached and how consistently the tablet is taken.

Appetite changes and weight loss develop at different rates for different people.

The dose is increased gradually towards the 25mg maintenance dose as prescribed. Reaching that dose does not mean you have reached your final weight-loss result: weight loss can continue over subsequent months. OASIS 4 assessed results at 64 weeks.

If you miss a dose of the Wegovy Pill, simply skip it and take your next tablet as usual the following day.

Do not take two tablets to make up for a missed dose, as this does not improve effectiveness and may increase side effects. Because the tablet must be taken on an empty stomach with the correct waiting period, it's best to keep your dosing time consistent rather than trying to catch up later.

You should only stay on a lower dose of the Wegovy Pill if your prescriber agrees it's clinically appropriate for you.

Some people remain on a lower dose long-term if they're achieving good results and tolerating it well. However, staying below the recommended 25mg maintenance dose purely to save money can reduce how effective treatment is, so any dose changes should be discussed with your prescriber rather than made independently.

Weight loss can plateau on the Wegovy Pill due to factors such as your current dose, calorie intake or metabolic adaptation.

Plateaus are a normal part of weight loss and don't necessarily mean the medicine has stopped working. Other contributors include not yet being on the maintenance dose or inconsistent timing of the tablet, which affects absorption. Speak to your prescriber if you're concerned, as they can review your technique, dose and lifestyle plan together.

If you stop taking the Wegovy Pill, your appetite is likely to return to previous levels and some weight regain is common.

This happens because the appetite-reducing effect of semaglutide fades once it clears your system, mirroring what's seen after stopping injectable semaglutide. Weight regain is more likely if diet and activity changes made during treatment aren't maintained. If you're considering stopping, speak to your prescriber first to discuss tapering and ongoing support.

A switch may be possible following an individual prescriber review. Tablets and injections are not interchangeable milligram for milligram.

UK prescribing information allows patients taking semaglutide 2.4mg injections weekly to transition to 25mg tablets daily, starting one week after the last injection, where appropriate. The response can vary because tablet absorption is more variable. Other doses or medicines require an individual plan. Do not stop, combine or switch treatment without your prescriber’s instructions.

Current evidence supports the safety of the Wegovy Pill for at least 64 weeks, though longer-term real-world data are still emerging.

This data comes from the OASIS clinical trial programme, which followed around 1,300 adults with obesity or overweight. Ongoing safety monitoring includes regular prescriber follow-up and the MHRA's Yellow Card scheme, which tracks side effects reported after a medicine reaches the market. Your prescriber will review your progress at regular intervals during treatment.

Alcohol is not strictly forbidden while taking the Wegovy Pill, but it can worsen common side effects such as nausea and dehydration.

Semaglutide can slow gastric emptying, which may change how alcohol affects you, and drinking can also make reflux or low blood sugar more likely, particularly in people with diabetes. Moderating alcohol intake, especially during dose increases, can help reduce discomfort.

You can take other medicines alongside the Wegovy Pill, but you must wait at least 30 minutes after your tablet before taking them.

This waiting period protects how well both the semaglutide and your other oral medicines are absorbed. Extra caution and monitoring are advised with levothyroxine and warfarin. Always give your prescriber a full list of your current medicines before starting, so they can check for interactions specific to your situation.

Yes, people with type 2 diabetes can be prescribed the Wegovy Pill, but it must never be used as a substitute for insulin.

If combined with insulin or a sulfonylurea, oral semaglutide can increase the risk of low blood sugar, known as hypoglycaemia, with symptoms including sweating, shaking and difficulty concentrating. Your prescriber may need to adjust your existing diabetes medicines when you start treatment.

Yes, travelling with the Wegovy Pill is straightforward, since the tablet does not require refrigeration unlike the Wegovy injection.

Keep your tablets in their original blister pack and protect them from excessive heat and moisture, and carry your Patient Information Leaflet in case you need it. If you're crossing time zones, try to keep your daily dosing routine as consistent as possible rather than doubling up if a day is missed.

If you find it hard to maintain the Wegovy Pill's empty-stomach and 30-minute wait routine, tell your prescriber, since this affects how well it works.

Taking the tablet with food, other drinks or too soon before other medicines reduces how much semaglutide is absorbed, which can make treatment less effective. Your prescriber may suggest ways to fit the routine into your day, or discuss whether the injectable form would suit your lifestyle better.

No, the Wegovy Pill must not be taken if you are pregnant, planning a pregnancy or breastfeeding, as there is not enough safety data in humans.

Animal studies have shown potential reproductive risk, and semaglutide is not recommended in these circumstances. If you become pregnant while taking the Wegovy Pill, stop the tablet and contact your doctor straight away so they can advise on managing your pregnancy safely going forward.

Yes, effective contraception is recommended throughout Wegovy Pill treatment and for at least two months after stopping, due to semaglutide's long half-life in the body.

This applies to anyone who could become pregnant while taking oral semaglutide, regardless of the contraceptive method used. Discuss suitable contraceptive options with your prescriber during your consultation, particularly if you are also taking hormonal contraception.

Studies of semaglutide have not shown a clinically significant effect on how well the combined oral contraceptive pill is absorbed or works.

You should still tell your prescriber if you take hormonal contraception, so it's recorded as part of your consultation. If you experience significant vomiting or diarrhoea while taking the Wegovy Pill, contraceptive absorption could be temporarily reduced, so using an additional barrier method during these episodes is a sensible precaution.

Do not take Wegovy tablets if you are allergic to semaglutide or another tablet ingredient. They should not be used during pregnancy or breastfeeding, and are not intended for under-18s.

Tell your prescriber about all medical conditions and medicines, including any history of pancreatitis, stomach-emptying problems, kidney or liver disease, diabetes-related eye problems, or thyroid disease. Some conditions require caution or mean treatment is not recommended. Do not combine Wegovy with another GLP-1 medicine or use it as a substitute for insulin. Your prescriber will assess suitability.

The Wegovy Pill contains semaglutide, which acts on GLP-1 receptors only, while Mounjaro contains tirzepatide, which acts on both GLP-1 and GIP receptors.

Mounjaro is currently available in the UK only as a weekly injection, as there is no licensed oral Mounjaro tablet. Some clinical evidence suggests tirzepatide may produce slightly greater average weight loss for some people, but individual response varies and the two medicines have different side effect profiles.

Yes, alternatives to the Wegovy Pill include injectable Wegovy, Mounjaro, Saxenda and Orlistat, alongside structured lifestyle and NHS weight-management programmes.

Injectable Wegovy and Mounjaro are weekly GLP-1 or dual GLP-1/GIP injections, Saxenda is a daily liraglutide injection, and Orlistat is an oral tablet that works differently, by reducing fat absorption in the gut rather than acting on appetite hormones. Your prescriber can help you weigh up which option best fits your goals, health needs and preferences.